Global Bacterial Vaccines Market By Type (Capsular Polysaccharide Vaccines, Toxoid Vaccines, Purified Protein Vaccines, Live Attenuated Bacterial Vaccines, Killed Bacterial Vaccines, Others), By Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019–2028
- Published date: Apr 2022
- Report ID: 25022
- Number of Pages: 294
- Format:
- keyboard_arrow_up
- 1. Global Bacterial Vaccines Market Introduction
- 1.1. Definition
- 1.2. Taxonomy
- 1.3. Research Scope
- 2. Executive Summary
- 2.1. Key Findings by Major Segments
- 2.2. Top strategies by Major Players
- 3. Global Bacterial Vaccines Market Overview
- 3.1. Global Bacterial Vaccines Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Opportunities
- 3.1.3. Restraints
- 3.1.4. Challenges
- 3.2. PESTLE Analysis
- 3.3. Opportunity Map Analysis
- 3.4. PORTER'S Five Forces Analysis
- 3.5. Market Competition Scenario Analysis
- 3.6. Product Life Cycle Analysis
- 3.7. Opportunity Orbits
- 3.8. Manufacturer Intensity Map
- 3.1. Global Bacterial Vaccines Market Dynamics
- 4. Global Bacterial Vaccines Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
- 4.1. Global Bacterial Vaccines Market Analysis by Type: Introduction
- 4.2. Market Size and Forecast by Region
- 4.3. Capsular Polysaccharide Vaccines
- 4.4. Toxoid Vaccines
- 4.5. Purified Protein Vaccines
- 4.6. Live Attenuated Bacterial Vaccines
- 4.7. Killed Bacterial Vaccines
- 4.8. Others
- 5. Global Bacterial Vaccines Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
- 5.1. Global Bacterial Vaccines Market Analysis by Application: Introduction
- 5.2. Market Size and Forecast by Region
- 5.3. Hospital Pharmacies
- 5.4. Retail Pharmacies
- 5.5. Online Pharmacies
- 6. Global Bacterial Vaccines Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
- 6.1. North America
- 6.1.1. North America Global Bacterial Vaccines Market: Regional Trend Analysis
- 6.1.1. 1.US
- 6.1.1. 2.Canada
- 6.1.1. 3.Mexico
- 6.1.1. North America Global Bacterial Vaccines Market: Regional Trend Analysis
- 6.2. Europe
- 6.2.1. Europe Global Bacterial Vaccines Market: Regional Trend Analysis
- 6.2.1.1. Germany
- 6.2.1.2. France
- 6.2.1.3. UK
- 6.2.1.4. Russia
- 6.2.1.5. Italy
- 6.2.1.6. Rest of Europe
- 6.2.1. Europe Global Bacterial Vaccines Market: Regional Trend Analysis
- 6.3. Asia-Pacific
- 6.3.1. Asia-Pacific Global Bacterial Vaccines Market: Regional Trend Analysis
- 6.3.1.1. China
- 6.3.1.2. Japan
- 6.3.1.3. Korea
- 6.3.1.4.India
- 6.3.1.5.Rest of Asia
- 6.3.1. Asia-Pacific Global Bacterial Vaccines Market: Regional Trend Analysis
- 6.4. Latin America
- 6.4.1. Latin America Global Bacterial Vaccines Market: Regional Trend Analysis
- 6.4.1.1. Brazil
- 6.4.1.2. Argentina
- 6.4.1.3. Rest of Latin America
- 6.4.1. Latin America Global Bacterial Vaccines Market: Regional Trend Analysis
- 6.5. Middle East and Africa
- 6.5.1. Middle East and Africa Global Bacterial Vaccines Market: Regional Trend Analysis
- 6.5.1.1. GCC
- 6.5.1.2. South Africa
- 6.5.1.3. Israel
- 6.5.1.4. Rest of MEA
- 6.5.1. Middle East and Africa Global Bacterial Vaccines Market: Regional Trend Analysis
- 6.1. North America
- 7. Global Bacterial Vaccines Market Competitive Landscape, Market Share Analysis, and Company Profiles
- 7.1. Market Share Analysis
- 7.2. Company Profiles
- 7.3. Pfizer
- 7.3.1. Company Overview
- 7.3.2. Financial Highlights
- 7.3.3. Product Portfolio
- 7.3.4. SWOT Analysis
- 7.3.5. Key Strategies and Developments
- 7.4. Merck
- 7.4.1. Company Overview
- 7.4.2. Financial Highlights
- 7.4.3. Product Portfolio
- 7.4.4. SWOT Analysis
- 7.4.5. Key Strategies and Developments
- 7.5. GlaxoSmithKline
- 7.5.1. Company Overview
- 7.5.2. Financial Highlights
- 7.5.3. Product Portfolio
- 7.5.4. SWOT Analysis
- 7.5.5. Key Strategies and Developments
- 7.6. Sanofi
- 7.6.1. Company Overview
- 7.6.2. Financial Highlights
- 7.6.3. Product Portfolio
- 7.6.4. SWOT Analysis
- 7.6.5. Key Strategies and Developments
- 7.7. PaxVax
- 7.7.1. Company Overview
- 7.7.2. Financial Highlights
- 7.7.3. Product Portfolio
- 7.7.4. SWOT Analysis
- 7.7.5. Key Strategies and Developments
- 7.8. Serum Institute of India
- 7.8.1. Company Overview
- 7.8.2. Financial Highlights
- 7.8.3. Product Portfolio
- 7.8.4. SWOT Analysis
- 7.8.5. Key Strategies and Developments
- 7.9. Emergent BioDefense Operations Lansing
- 7.9.1. Company Overview
- 7.9.2. Financial Highlights
- 7.9.3. Product Portfolio
- 7.9.4. SWOT Analysis
- 7.9.5. Key Strategies and Developments
- 8. Assumptions and Acronyms
- 9. Research Methodology
- 10. Contact
- 1. Global Bacterial Vaccines Market Introduction
- Pfizer Inc Company Profile
- Merck KGaA Company Profile
- GlaxoSmithKline
- Sanofi Company Profile
- PaxVax
- Serum Institute of India
- Emergent BioDefense Operations Lansing
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible|
Single User
$5,999
$2,999
USD / per unit
save 50% |
Multi User
$7,999
$3,499
USD / per unit
save 55% |
Corporate User
$12,999
$4,499
USD / per unit
save 65% | |
|---|---|---|---|
| e-Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 2,999) | Buy Now ($ 3,499) | Buy Now ($ 4,499) |

